Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
2.7
2.8
Journals
Healthcare
Special Issues
Breast Cancer Diagnosis, Prevention and Control
share announcement

Breast Cancer Diagnosis, Prevention and Control

A special issue of Healthcare (ISSN 2227-9032).

Deadline for manuscript submissions: closed (16 January 2024) | Viewed by 1305

Special Issue Editors

Dr. Beata Pięta

E-Mail Website
Guest Editor
Department of Mother and Child Health, Faculty of Health Sciences, Poznan University of Medical Sciences, Polna Street 33, 60-535 Poznań, Poland
Interests: breast cancer management; gynecology; pregnancy; woman
Special Issues, Collections and Topics in MDPI journals
Prof. Dr. Paweł Rzymski

E-Mail Website
Co-Guest Editor
Department of Mother and Child Health, Faculty of Health Sciences, Poznan University of Medical Sciences, Polna Street 33, 60-535 Poznań, Poland
Interests: pregnancy; breast cancer and imaging; woman oncology

Special Issue Information

Dear Colleagues,

Neoplasms are common and cause concern in medical healthcare systems. There is growing evidence of environmental risk factors that can be monitored. Thus,  research has led to better prophylaxis and reduced exposition. There is a strong need to intensify prevention, health education and proper lifestyle promotion. However,  secondary activity, including modern diagnostics, increases early diagnosis, leading to increased successful oncologic treatment.

In this Special Issue concerning breast cancer, we will discuss a wide variety of topics with an emphasis on the advances and novel areas of interest:

  • Depression, oncologic psychology in breast cancer
  • Breast cancer during pregnancy
  • Modern screening
  • Modern/advances in diagnostics
  • Advances in breast cancer treatment (surgery, radiotherapy, chemotherapy, immunotherapy, etc.)
  • Quality of life in breast cancer patients
  • Genetics in breast cancer
  • Influence of COVID-19 pandemic on breast cancer risks, treatment
  • Environmental risks of breast cancer
  • Diet and health promotion in breast cancer

Healthcare is the forum of multidisciplinary discussion, we invite authors to publish research (original) or state-of-the-art review in their field of interest in an open journal with impact factor.

Dr. Beata Pięta
Prof. Dr. Paweł Rzymski
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • breast cancer
  • depression
  • pregnancy
  • woman
  • lifestyle
  • breast cancer treatment
  • breast cancer diagnosis
  • screening
  • genes
  • quality of life

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

16 pages, 501 KiB  
Article
Development and Psychometric Validation of the Breast Cancer Stigma Assessment Scale for Women with Breast Cancer and Its Survivors
by Judit Cenit-García, Carolina Buendia-Gilabert, Carmen Contreras-Molina, Daniel Puente-Fernández, Rafael Fernández-Castillo and María Paz García-Caro
Healthcare 2024, 12(4), 420; https://doi.org/10.3390/healthcare12040420 - 06 Feb 2024
Viewed by 946
Abstract
Background: The increase in breast cancer cases and breast cancer survival makes it advisable to quantify the impact of the health-related stigma of this disease. Purpose/Objectives: To develop and validate a breast cancer stigma scale in Spanish. Methods: Women diagnosed with, or survivors [...] Read more.
Background: The increase in breast cancer cases and breast cancer survival makes it advisable to quantify the impact of the health-related stigma of this disease. Purpose/Objectives: To develop and validate a breast cancer stigma scale in Spanish. Methods: Women diagnosed with, or survivors of, breast cancer were included. The development of the Breast Cancer Stigma Assessment Scale (BCSAS) involved both a literature review and personal interviews. Content validity was assessed using a Delphi study and a pilot test; construct validity was evaluated using an exploratory factor analysis; and convergent validity was assessed using six scales. Cronbach’s α internal consistency and test-retest reliability were used to determine the reliability of the scales. Results: 231 women responded to the 28-item scale. The BCSAS showed good reliability, with α = 0.897. Seven factors emerged: concealment (α = 0.765), disturbance (α = 0.772), internalized stigma (α = 0.750), aesthetics (α = 0.779), course (α = 0.599), danger (α = 0.502), and origin (α = 0.350). The test-retest reliability was 0.830 (p < 0.001). Significant correlation was observed with event centrality (r = 0.701), anxiety–depression (r = 0.668), shame (r = 0.645), guilt (r = 0.524), and quality of life (r = −0.545). Conclusions: The BCSAS is a reliable and valid measure of stigma in women with breast cancer and its survivors. It could be useful for detecting stigma risk and establishing psychotherapeutic and care priorities. Full article
(This article belongs to the Special Issue Breast Cancer Diagnosis, Prevention and Control)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop